Functional differences between human formyl peptide receptor isoforms 26, 98, and G6
Authors:
- 1 May 2003
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 367 (5) , 509-515
Abstract
The formyl peptide receptor (FPR) is expressed in neutrophils, couples to Gi-proteins and activates phospholipase C, chemotaxis and cytotoxic cell functions. FPR isoforms 26, 98, and G6 differ from each other in amino acids 101, 192 and 346 (FPR-26: V101, N192, E346; FPR-98: L101, N192, A346; FPR-G6: V101, K192, A346), but the functional significance of those structural differences is unknown. In order to address this question, we analyzed FPR-26, FPR-98 and FPR-G6 by co-expressing recombinant FLAG epitope-tagged FPRs with the G-protein Giα2β1γ2 in Sf9 insect cells and measured high-affinity agonist binding and guanosine 5'-O-(3-thiotriphosphate) (GTPγS) binding. The B max values of high-affinity agonist binding with FPR-98 and FPR-G6 were much lower than with FPR-26. FPR-98 and FPR-G6 activated considerably fewer Gi-proteins, and were much less constitutively active, than FPR-26. Whereas FPR-26 migrated as a monomer in SDS polyacrylamide electrophoresis, FPR-98 and FPR-G6 migrated as dimers and tetramers. In terms of immunoreactivity, FRP-98 and FPR-G6 were expressed at higher levels than FPR-26. Single amino acid exchanges at positions 101 (V→L), 192 (N→K) and 346 (E→A) in FPR-26 revealed that E346 accounts for FPR-26 migrating as a monomer and the high constitutive activity of FPR-26. The V101L, N192K and E346A exchanges all reduced high-affinity agonist binding and the number of Gi-proteins activated by FPR-26. We conclude that (i) FPR isoforms 98 and G6 exhibit a partial Gi-protein coupling defect relative to FPR-26 and that (ii) E346 critically determines constitutive activity, Gi-protein coupling and physical state of FPR-26.Keywords
This publication has 22 references indexed in Scilit:
- Identification of Putative Sites of Interaction between the Human Formyl Peptide Receptor and G ProteinJournal of Biological Chemistry, 1999
- High Constitutive Activity of the Human Formyl Peptide ReceptorJournal of Biological Chemistry, 1998
- Constitutive activity of human prostaglandin E receptor EP3 isoformsBritish Journal of Pharmacology, 1997
- The Molecular Biology of Leukocyte Chemoattractant ReceptorsAnnual Review of Immunology, 1994
- Sequence and organization of the human N-formyl peptide receptor-encoding geneGene, 1993
- Cyclosporin H is a potent and selective formyl peptide receptor antagonist. Comparison with N-t-butoxycarbonyl-L-phenylalanyl-L-leucyl-L-phenylalanyl-L- leucyl-L-phenylalanine and cyclosporins A, B, C, D, and EThe Journal of Immunology, 1993
- Absence of G(i) proteins in the Sf9 insect cell. Characterization of the uncoupled recombinant N-formyl peptide receptor.Journal of Biological Chemistry, 1992
- Regulation of the superoxide-forming NADPH oxidase of human neutrophils is not altered in essential hypertensionJournal Of Hypertension, 1991
- The superoxide-forming NADPH oxidase of phagocytes. An enzyme system regulated by multiple mechanisms.1991
- Dual Mg2+ control of formyl‐peptide‐receptor–G‐protein interaction in HL 60 cellsEuropean Journal of Biochemistry, 1989